Medisbee Announces Clinical Study of Rehabilitation Robot ROBOARM...Improvement of treatment effectiveness and efficiency
Oct 29, 2025
Medisbee (CEO Lim Joon-yeol), a medical and physical AI company, announced that it unveiled the main results of clinical research on the upper-lower part all-in-one rehabilitation robot 'ROBOARM' at the international academic conference 'CAOS Asia-Pacific 2025' hosted by the Korean Orthopedic Computer Surgery Association from the 24th to the 25th.
According to the company, the study was conducted on patients with limited range of joint motion, and ROBOARM explained that it was possible to recover three types of range of joint motion per treatment, and that the range of motion before and after treatment improved by an average of 20 degrees.
In addition, overall treatment safety was proven during the clinical trial, and the working hours of therapists who are used for repetitive rehabilitation tasks were also reduced from 30 minutes to less than 5 minutes, reducing the burden on medical staff.
Founded in 2024 as a co-founder of Severance Hospital and Yonsei University's artificial intelligence faculty, MedisB focuses on upgrading 'All-in-One' robotic technology applicable to both upper and lower extremities and 'Physical AI' technology based on treatment path input.
A Medisbee official said "ROBOARM is a tool that assists and expands the specialized capabilities of therapists, and automatically repeats patient-specific treatment paths to present a new robotic treatment paradigm in the medical field." he said.
CEO Lim Joon-yeol (Gangnam Severance Hospital) said, "Through this clinical study, when creating a 'Guide Path' with the therapist's expertise, we were able to perform it precisely with the ROBOARM solution to capture both treatment effect and stability"We plan to continue to conduct various studies in the future to specifically demonstrate how effective and safe ROBOARM, which complements medical staff and robotic technology, can be used in clinical settings."
Meanwhile, MedisB has recently been selected as a target for global accelerating 'NVIDIA Inception' program and the Ministry of SMEs and Startups 'Deep Tech TIPS' of global AI leader Nvidia, and plans to accelerate the development of medical physical AI solutions and commercialization at home and abroad.
According to the company, the study was conducted on patients with limited range of joint motion, and ROBOARM explained that it was possible to recover three types of range of joint motion per treatment, and that the range of motion before and after treatment improved by an average of 20 degrees.
In addition, overall treatment safety was proven during the clinical trial, and the working hours of therapists who are used for repetitive rehabilitation tasks were also reduced from 30 minutes to less than 5 minutes, reducing the burden on medical staff.
Founded in 2024 as a co-founder of Severance Hospital and Yonsei University's artificial intelligence faculty, MedisB focuses on upgrading 'All-in-One' robotic technology applicable to both upper and lower extremities and 'Physical AI' technology based on treatment path input.
A Medisbee official said "ROBOARM is a tool that assists and expands the specialized capabilities of therapists, and automatically repeats patient-specific treatment paths to present a new robotic treatment paradigm in the medical field." he said.
CEO Lim Joon-yeol (Gangnam Severance Hospital) said, "Through this clinical study, when creating a 'Guide Path' with the therapist's expertise, we were able to perform it precisely with the ROBOARM solution to capture both treatment effect and stability"We plan to continue to conduct various studies in the future to specifically demonstrate how effective and safe ROBOARM, which complements medical staff and robotic technology, can be used in clinical settings."
Meanwhile, MedisB has recently been selected as a target for global accelerating 'NVIDIA Inception' program and the Ministry of SMEs and Startups 'Deep Tech TIPS' of global AI leader Nvidia, and plans to accelerate the development of medical physical AI solutions and commercialization at home and abroad.
|
This article was translated by Naver AI translator.
